A Comprehensive Single-Center Analysis of Postoperative Nausea and Vomiting Following Orthognathic Surgery.


Journal

The Journal of craniofacial surgery
ISSN: 1536-3732
Titre abrégé: J Craniofac Surg
Pays: United States
ID NLM: 9010410

Informations de publication

Date de publication:
Historique:
pubmed: 13 9 2021
medline: 9 4 2022
entrez: 12 9 2021
Statut: ppublish

Résumé

Postoperative nausea and vomiting (PONV) remains a major clinical end-point for directing enhanced recovery after surgery (ERAS) protocols in facial plastic surgery. This study aimed to identify risk factors for PONV and evaluate strategies for PONV reduction in orthognathic surgery patients. A retrospective cohort study was performed among patients receiving orthognathic surgery at our institution from 2011 to 2018. Patient demographics, surgical operative and anesthesia notes, medications, and nausea/vomiting were assessed for each patient. The amount of opioid analgesia given both perioperatively and postoperatively was recorded and converted into morphine equivalents (MEQ). Stepwise regression analysis was used to identify significant risk factors for PONV. Post hoc analyses were employed to compare PONV among patients based on MEQ dosage and antiemetic prophylaxis regimes. A total of 492 patients were included; mean age was 23.0 years (range: 13-60); 54.4% were female. The majority of patients received concurrent Le Fort I osteotomy, BSSO, and genioplasty (70.1%). During hospitalization, 59.4% of patients experienced nausea requiring antiemetic medications and 28.4% experienced emesis. Stepwise regression yielded Apfel scores (P = 0.003) and postoperative opioids (P = 0.013) as the strongest predictors of PONV. Post hoc analyses showed that undertreatment with prophylactic antiemetics (based on Apfel) predicted increased PONV (+12.9%, P = 0.020), and that lower postoperative MEQs (<28.0) predicted decreased PONV (-11.8%, P = 0.01). The study findings confirm the high incidence of PONV among orthognathic surgical patients and stratify previously reported PONV risk factors. More aggressive utilization of antiemetic medications and decreased dependence on opioid analgesia may decrease nausea/vomiting following orthognathic surgery.

Sections du résumé

BACKGROUND BACKGROUND
Postoperative nausea and vomiting (PONV) remains a major clinical end-point for directing enhanced recovery after surgery (ERAS) protocols in facial plastic surgery. This study aimed to identify risk factors for PONV and evaluate strategies for PONV reduction in orthognathic surgery patients.
METHODS METHODS
A retrospective cohort study was performed among patients receiving orthognathic surgery at our institution from 2011 to 2018. Patient demographics, surgical operative and anesthesia notes, medications, and nausea/vomiting were assessed for each patient. The amount of opioid analgesia given both perioperatively and postoperatively was recorded and converted into morphine equivalents (MEQ). Stepwise regression analysis was used to identify significant risk factors for PONV. Post hoc analyses were employed to compare PONV among patients based on MEQ dosage and antiemetic prophylaxis regimes.
RESULTS RESULTS
A total of 492 patients were included; mean age was 23.0 years (range: 13-60); 54.4% were female. The majority of patients received concurrent Le Fort I osteotomy, BSSO, and genioplasty (70.1%). During hospitalization, 59.4% of patients experienced nausea requiring antiemetic medications and 28.4% experienced emesis. Stepwise regression yielded Apfel scores (P = 0.003) and postoperative opioids (P = 0.013) as the strongest predictors of PONV. Post hoc analyses showed that undertreatment with prophylactic antiemetics (based on Apfel) predicted increased PONV (+12.9%, P = 0.020), and that lower postoperative MEQs (<28.0) predicted decreased PONV (-11.8%, P = 0.01).
CONCLUSIONS CONCLUSIONS
The study findings confirm the high incidence of PONV among orthognathic surgical patients and stratify previously reported PONV risk factors. More aggressive utilization of antiemetic medications and decreased dependence on opioid analgesia may decrease nausea/vomiting following orthognathic surgery.

Identifiants

pubmed: 34510064
doi: 10.1097/SCS.0000000000008052
pii: 00001665-900000000-92249
doi:

Substances chimiques

Analgesics, Opioid 0
Antiemetics 0
Morphine 76I7G6D29C

Types de publication

Journal Article

Langues

eng

Pagination

584-587

Informations de copyright

Copyright © 2021 by Mutaz B. Habal, MD.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Myles PS, Williams DL, Hendrata M, et al. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth 2000; 84:6–10.
Mc Loughlin S, Terrasa SA, Ljungqvist O, et al. Nausea and vomiting in a colorectal ERAS program: impact on nutritional recovery and the length of hospital stay. Clin Nutr ESPEN 2019; 34:73–80.
Apfel CC, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91:693–700.
Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2020; 131:411–448.
Manahan MA, Johnson DJ, Gutowski KA, et al. Postoperative nausea and vomiting with plastic surgery: a practical advisory to etiology, impact, and treatment. Plast Reconstr Surg 2018; 141:214–222.
Bartlett EL, Zavlin D, Friedman JD, et al. Enhanced recovery after surgery: the plastic surgery paradigm shift. Aesthet Surg J 2017; 38:676–685.
Dobbeleir M, De Coster J, Coucke W, et al. Postoperative nausea and vomiting after oral and maxillofacial surgery: a prospective study. Int J Oral Maxillofac Surg 2018; 47:721–725.
Silva AC, O’Ryan F, Poor DB. Postoperative nausea and vomiting (PONV) after orthognathic surgery: a retrospective study and literature review. J Oral Maxillofac Surg 2006; 64:1385–1397.
Ghosh S, Rai KK, Shivakumar HR, et al. Incidence and risk factors for postoperative nausea and vomiting in orthognathic surgery: a 10-year retrospective study. J Korean Assoc Oral Maxillofac Surg 2020; 46:116–124.
Pierre S, Whelan R. Nausea and vomiting after surgery. Education in Anaesthesia Critical Care & Pain 2012; 13:28–32.
PONV Prophylaxis Guidelines. Stanford Medicine Resources for Anesthesia Research and Education. Available at: https://ether.stanford.edu/policies/PONV_prophylaxis_guidelines.html. Published 2014. Accessed January 30, 2014
Shaikh SI, Nagarekha D, Hegade G, et al. Postoperative nausea and vomiting: a simple yet complex problem. Anesth Essays Res 2016; 10:388–396.
Roberts RG, Jones RM. Paediatric tonsillectomy and PONV -- big little problem remains big!. Anaesthesia 2002; 57:619–620.
Apfel Christian C, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91:693–1693.
Weilbach C, Rahe-meyer N, Raymondos K, et al. Postoperative nausea and vomiting (PONV): usefulness of the Apfel-score for identification of high risk patients for PONV. Acta Anaesthesiol Belg 2006; 57:361–363.
Weibel S, Jelting Y, Pace NL, et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev 2017; (11):CD012859.
Dewinter G, Staelens W, Veef E, et al. Simplified algorithm for the prevention of postoperative nausea and vomiting: a before-and-after study. Br J Anaesth 2018; 120:156–163.
Apfel CC, Stoecklein K, Lipfert P. PONV: a problem of inhalational anaesthesia? Best Pract Res Clin Anaesthesiol 2005; 19:485–500.
Ho C-M, Wu H-L, Ho S-T, et al. Dexamethasone prevents postoperative nausea and vomiting: benefit versus risk. Acta Anaesthesiol Taiwan 2011; 49:100–104.
Chegini S, Dhariwal DK. Review of evidence for the use of steroids in orthognathic surgery. Br J Oral Maxillofac Surg 2012; 50:97–101.
Yu Y, Lin H, Wu Z, et al. Perioperative combined administration of tranexamic acid and dexamethasone in total knee arthroplasty-benefit versus harm? Medicine (Baltimore) 2019; 98:e15852.
Yavuz MS, Kazanci D, Turan S, et al. Investigation of the effects of preoperative hydration on the postoperative nausea and vomiting. Biomed Res Int 2014; 2014:302747.
Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118:85–113.
Tang J, Chen X, White Paul F, et al. Antiemetic prophylaxis for office-based surgery: are the 5-HT3Receptor antagonists beneficial? Anesthesiology 2003; 98:293–298.
Alexander M, Krishnan B, Yuvraj V. Prophylactic antiemetics in oral and maxillofacial surgery: a requiem? J Oral Maxillofac Surg 2009; 67:1873–1877.
Roberts GW, Bekker TB, Carlsen HH, et al. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 2005; 101:1343–1348.
Mobini A, Mehra P, Chigurupati R. Postoperative pain and opioid analgesic requirements after orthognathic surgery. J Oral Maxillofac Surg 2018; 76:2285–2295.
Lieblich SE, Danesi H. Liposomal bupivacaine use in third molar impaction surgery: INNOVATE study. Anesth Prog 2017; 64:127–135.
Macario A, Royal MA. A literature review of randomized clinical trials of intravenous acetaminophen (paracetamol) for acute postoperative pain. Pain Pract 2011; 11:290–296.

Auteurs

Navid Pourtaheri (N)

Division of Plastic and Reconstructive Surgery, Indiana University School of Medicine, Indianapolis, IN.

Connor J Peck (CJ)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Seija Maniskas (S)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Kitae E Park (KE)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Omar Allam (O)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Ludmila Chandler (L)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

John Smetona (J)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Jenny Yang (J)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Alexander Wilson (A)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Jacob Dinis (J)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Joseph Lopez (J)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Derek M Steinbacher (DM)

Plastic and Reconstructive Surgery, Oral and Maxillofacial Surgery, Yale New Haven Health, New Haven CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH